ACRS - CIK 0001557746
Aclaris Therapeutics, Inc. has filed 852 documents with the SEC between 2012 and 2026. The most frequent type is insider trade (370 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| SCHEDULE 13G | - | 2025-07-29 | - |
| SCHEDULE 13G/A | - | 2025-07-24 | - |
| SCHEDULE 13G | - | 2025-07-17 | - |
| Major company event | 8-K | 2025-06-30 | 2025-06-30 |
| Insider trade | 4 | 2025-06-09 | 2025-06-05 |
| Insider trade | 4 | 2025-06-09 | 2025-06-05 |
| Insider trade | 4 | 2025-06-09 | 2025-06-05 |
| Insider trade | 4 | 2025-06-09 | 2025-06-05 |
| Insider trade | 4 | 2025-06-09 | 2025-06-05 |
| Insider trade | 4 | 2025-06-09 | 2025-06-05 |
| Major company event | 8-K | 2025-06-05 | 2025-06-05 |
| Employee stock plan | S-8 | 2025-06-05 | - |
| SCHEDULE 13G/A | - | 2025-05-15 | - |
| SCHEDULE 13G/A | - | 2025-05-12 | - |
| Quarterly report | 10-Q | 2025-05-08 | 2025-03-31 |
| Major company event | 8-K | 2025-05-08 | 2025-05-08 |
| Insider trade | 4 | 2025-05-05 | 2025-05-01 |
| New insider ownership | 3 | 2025-05-05 | 2025-05-01 |
| Insider trade | 4 | 2025-05-05 | 2025-05-01 |
| SCHEDULE 13G | - | 2025-05-05 | - |
| SCHEDULE 13G/A | - | 2025-04-30 | - |
| Annual report to shareholders | ARS | 2025-04-24 | 2024-12-31 |
| Proxy materials | DEFA14A | 2025-04-24 | - |
| Proxy statement | DEF 14A | 2025-04-24 | 2025-06-05 |
| PRE 14A | - | 2025-04-14 | 2025-06-05 |
| Insider trade | 4 | 2025-04-03 | 2025-04-01 |
| EFFECT | - | 2025-03-07 | - |
| Company correspondence | CORRESP | 2025-03-05 | - |
| Insider trade | 4 | 2025-03-04 | 2025-03-01 |
| Insider trade | 4 | 2025-03-04 | 2025-03-01 |
| Insider trade | 4 | 2025-03-04 | 2025-03-01 |
| SEC correspondence | UPLOAD | 2025-03-04 | - |
| Annual report | 10-K | 2025-02-27 | 2024-12-31 |
| Major company event | 8-K | 2025-02-27 | 2025-02-27 |
| Securities registration | S-3 | 2025-02-27 | - |
| SCHEDULE 13G/A | - | 2025-02-13 | - |
| SCHEDULE 13G | - | 2025-02-12 | - |
| Insider trade | 4 | 2025-02-04 | 2025-02-03 |
| Insider trade | 4 | 2025-02-04 | 2025-02-01 |
| Insider trade | 4 | 2025-02-04 | 2025-02-01 |
| Insider trade | 4 | 2025-02-04 | 2025-02-01 |
| Insider trade | 4 | 2025-02-04 | 2025-02-01 |
| Major company event | 8-K | 2025-01-13 | 2025-01-13 |
| Insider trade | 4 | 2025-01-03 | 2024-12-31 |
| Insider trade | 4 | 2025-01-03 | 2024-12-31 |
| Insider trade | 4 | 2025-01-03 | 2024-12-31 |
| Insider trade | 4 | 2025-01-03 | 2025-01-01 |
| EFFECT | - | 2024-12-31 | - |
| 424B3 | - | 2024-12-31 | - |
| Company correspondence | CORRESP | 2024-12-27 | - |